Skip to main content

Weight loss drugs (GLP 1 Agonists, Mounjaro, Ozempic etc)

We understand there has been significant media coverage regarding these drugs and their availability. We want to clarify that these medications are not currently available on demand. Our practice is awaiting the launch of an Integrated Care Board (ICB) Weight Management and Complex Obesity Service (WMCOS), which will provide comprehensive support for eligible patients. Until this service is operational, we encourage patients to continue focusing on healthy lifestyle choices and consult with us for personalised advice.

Disclaimer

Every effort is taken to ensure that the information published on this website is accurate and informative.

This website is provided for information only. It is not intended to replace a consultation with an appropriately qualified medical practitioner. Neither the practice nor any of its sub-contractors can accept responsibility for any loss, damage or injury that arises from the use of this website.

Links are provided for information and convenience only. We cannot accept responsibility for the sites linked to, or the information found there. A link does not imply an endorsement of a site; likewise, not linking to a particular site does not imply lack of endorsement.

We make every effort to ensure that this website is available 24 hours a day, 365 days a year. However, we cannot guarantee uninterrupted access to this website, or the sites to which it links. We accept no responsibility for any damages arising from the loss of use of this information.

Page published: 5 May 2023
Last updated: 5 May 2023